Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Gencivenz-200 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Gencivenz-200

Approved

STANDARD

Gencivenz-200

Shilpa Medicare Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 2a80a4ee3d104055
Company: Shilpa Medicare Limited
Type: Standard

Approval Details

Approval Id: 2a80a4ee3d104055
Drug Approval Philippines Name: Gencivenz-200
Product Name: Gencivenz-200
Registration Number: DRP-10643
Brand Name: Gencivenz-200
Generic Name: Gemcitabine (as Hydrochloride)
Dosage Form: Lyophilized Powder For Injection (IV Infusion)
Dosage Strength: 200 mg
Manufacturer: Shilpa Medicare Limited
Importer: Ambica International Corporation
Distributor: Ambica International Corporation
Company Detail Path: /organization/shilpa-medicare-limited
Issuance Date: 26 October 2021
Expiry Date: 26 October 2026
Pharmacologic Category: Antineoplastic (Pyrimidine Analogue)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

2a80a4ee3d104055

Type

Standard

Back to Philippines FDA Approvals